Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenazopyridine for Postoperative Urinary Retention (EPOV)
NCT03065075Phase 3Completed
- Sponsor
- University of Massachusetts
- Start
- Feb 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of phenazopyridine in urinary retention, sponsored by University of Massachusetts. Started Feb 2017; status: completed.
02
Drugs
phenazopyridine
03
Conditions
urinary retention
Beyond the preview
Go deeper on NCT03065075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03065075.